Koyfin Home > Directory > Health Care > Aduro Biotech > Return on Capital %

Aduro Biotech Return on Capital % Chart (ADRO)

Aduro Biotech annual/quarterly Return on Capital % from 2014 to 2020.
  • Aduro Biotech Return on Capital % for the quarter ending June 06, 2020 was -43.52 a 10.64% decrease of -4.63 year over year
  • Aduro Biotech Return on Capital % for the last 12 months ending June 06, 2020 was -39.10 a 0.42% decrease of -0.16 year over year
  • Aduro Biotech Annual Return on Capital % for 2019 was -44.78 a 27.10% decrease of -12.13 from 2018
  • Aduro Biotech Annual Return on Capital % for 2018 was -32.65 a 12.29% decrease of -4.01 from 2017
  • Aduro Biotech Annual Return on Capital % for 2017 was -28.64 a 35.83% decrease of -10.26 from 2016
Other Margins & Efficiency Metrics:
  • Aduro Biotech EBITDA Margin for the quarter ending June 06, 2016 was $10m a 1,081.69% increase of 105m year over year
  • Aduro Biotech Return on Equity % for the quarter ending December 12, 2018 was -71.86 a 44.92% decrease of -32.28 year over year
View Chart On Koyfin

Quarterly ADRO Return on Capital % Data

06/2020-43.52
03/2020-25.65
12/2019-47.89
09/2019-38.89
06/2019-34.60
03/2019-38.42
12/2018-40.97
09/2018-37.27
06/2018-34.49
03/2018-26.12

Annual ADRO Return on Capital % Data

2019-44.78
2018-32.65
2017-28.64
2016-18.38
2015-4.77
2014-28.02
2013-219.13